Cite
HARVARD Citation
van der Heijde, D. et al. (2019). Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial. Lancet. 394 (10214), pp. 2108-2117. [Online].